Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT. - Wikidata - wikimedia - TriplyDB

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

http://www.wikidata.org/entity/Q37187172

about

Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma.Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.A new predictive scoring system based on clinical data and computed tomography features for diagnosing EGFR-mutated lung adenocarcinoma.

P2860

Q47105235-DEF212C6-D40F-4B1E-A8C4-D4410C1D06E9 Q47843944-FF614AB1-B209-4CB2-B282-CA5C4467DEAF Q55058129-2E866DE5-A954-46DC-BEDA-DC2669A97ACD

P2860

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

http://www.wikidata.org/entity/Q37187172

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 June 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@en

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@nl

type

label

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@en

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@nl

prefLabel

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@en

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@nl

P1433

Q37187172-EF9C9B6C-F762-4DCD-86DB-84FC8CB56C3C

P1476

Q37187172-414CB230-FE3F-474C-899C-2BA19D282CF0

P2093

Q37187172-35A845A0-CBB5-40D6-9F32-52BEAF466409

Q37187172-3E4344B3-48A4-4A65-993F-FC4B83F70D1C

Q37187172-4E3FFA7A-0F93-4F1F-A338-407D09572E04

Q37187172-573C9B99-DE09-4F05-AA8C-33A8DC192062

Q37187172-89605FD3-283B-4CB9-97E1-EB9C7557B6E3

Q37187172-D13461BB-26CA-48BA-A292-A4843B64BC70

P2860

Q37187172-0CAD141D-4333-4ED5-A852-B2F78385AFEA

Q37187172-1BE949B8-13CA-4006-8DBF-C53D5C1B6345

Q37187172-33A2DA3B-3A18-4F5F-9E37-7A84C91B7775

Q37187172-358A7ADA-A97B-41DD-9AA7-6613C37078ED

Q37187172-47B98A70-EB63-4D23-8F52-48A59681698C

Q37187172-48058B3C-2F16-4BB4-979B-C35785EEC7AD

Q37187172-563E9B5A-6015-43A4-90F0-B69DB37DBCFE

Q37187172-6850C723-868F-4F78-880B-44B6AE315645

Q37187172-8F1B9B1A-A857-4A6B-A3D4-E5CFA8FC6ABE

Q37187172-A371D8F3-E67B-4E67-A93A-A4B9015603AF

P304

Q37187172-0723E494-171E-4418-A738-B6B0D6502FD2

P31

Q37187172-7842BEFB-1D0D-4C61-BCDD-F194500D7EC1

P356

Q37187172-48AC68AA-645B-4019-8FC3-BD6A1DB63C9E

P433

Q37187172-64719B78-66E4-4139-8761-E6151D32EEFF

P478

Q37187172-5DA3C3FF-F27A-49C0-80B8-300AF7992E7B

P50

Q37187172-138EDB1C-8BD3-4A14-B32E-97A75D0DF1C0

P577

Q37187172-FF66A657-5F69-4819-9B5D-9C293A69E0A3

P5875

Q37187172-4E32FF7C-EE00-42E8-881E-2C43F418BC2D

P698

Q37187172-602B34FC-309C-4CD8-88A8-9E5D4969D9F4

P921

Q37187172-96EBA681-84BF-4B28-9EC8-64E9387E8850

P932

Q37187172-1F9A0988-2B1E-4120-883A-A4165A4B4807

P356

ATCS.OA.14-00093

P1433

Annals of Thoracic and Cardiovascular Surgery

P1476

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

@en

P2093

Hiroaki Kuroda

http://www.w3.org/2001/XMLSchema#string

Hirofumi Uehara

http://www.w3.org/2001/XMLSchema#string

Ken Nakagawa

http://www.w3.org/2001/XMLSchema#string

Mingyon Mun

http://www.w3.org/2001/XMLSchema#string

Sakae Okumura

http://www.w3.org/2001/XMLSchema#string

Takeo Nakada

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking

Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.

Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study.

Comprehensive histologic analysis of ALK-rearranged lung carcinomas.

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.

P304

102-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5761/ATCS.OA.14-00093

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262884937

http://www.w3.org/2001/XMLSchema#string

P698

24899136

http://www.w3.org/2001/XMLSchema#string

P921

P932

4990087

http://www.w3.org/2001/XMLSchema#string